Ripretinib in the treatment of patients with advanced gastrointestinal stromal tumors (GIST)

Emilia Babula, Aleksandra Sikora, Paweł Sobczuk, Piotr Rutkowski

Vol 20, No 1 (2024)

Review paper

Diagnostic and therapeutic management of cancer patients with pain: recommendations of the Expert Group of the Polish Association for Palliative Care, Polish Association for the Study of Pain, and Polish Association of Clinical Oncology

Wojciech Leppert, Jerzy Wordliczek, Małgorzata Malec-Milewska, Magdalena Kocot-Kępska, Jarosław Woroń, Renata Zajączkowska, Jan Dobrogowski, Maciej Krzakowski, Małgorzata Krajnik

Vol 20, No 2 (2024)

Guidelines / Expert consensus

Management of melanoma central nervous system metastases

Piotr Rutkowski, Dorota Kiprian, Tomasz Świtaj, Radosław Michalik, Mateusz Spałek, Katarzyna Kozak, Tomasz Mandat, Bożena Cybulska-Stopa, Monika Dudzisz-Śledź

Ahead of print

Guidelines / Expert consensus

Convolutional neural networks in auto-segmentation of nasopharyngeal carcinoma tumor — a systematic review and meta-analysis

Maryam Zamanian, Iraj Abedi

Vol 20, No 1 (2024)

Review paper

Cardiac metastasis of lung cancer diagnosed by fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT)

Yassir Benameur, Salah Nabih Oueriagli, Omar Ait Sahel, Abderrahim Doudouh

Vol 20, No 2 (2024)

Case report

Commentary on Trastuzumab deruxtecan in the treatment of adult patients with HER-positive breast cancer

Maciej Krzakowski

Vol 19, No 5 (2023)

Commentary

Trastuzumab deruxtecan in the treatment of adult patients with HER2-positive breast cancer

Joanna Kufel-Grabowska

Vol 19, No 5 (2023)

Review paper

ERRATUM: Trastuzumab deruxtecan in the treatment of adult patients with HER2-positive breast cancer

Joanna Kufel-Grabowska

Vol 20, No 1 (2024)

Erratum

Non-drug related costs of treatment with pertuzumab and trastuzumab in HER2-positive breast cancer patients in Poland

Michał Seweryn, Tomasz Banaś, Joanna Augustyńska, Agnieszka Leszczyńska, Paweł M. Potocki

Ahead of print

Research paper

Commentary on Encorafenib plus cetuximab in patients with BRAFV600E-mutated metastatic colorectal cancer — Polish multicenter experience

Barbara Radecka

Ahead of print

Commentary

Sotorasib for non-small cell lung cancer — current options and perspectives

Magdalena Knetki-Wróblewska, Bartosz Wasąg

Ahead of print

Review paper

Evaluation of the Timed Up and Go test for screening vulnerability and frailty in older cancer patients

Teodoro J. Oscanoa, Edwin Cieza-Macedo, Xavier Vidal, Roman Romero-Ortuno

Vol 20, No 1 (2024)

Research paper

Pembrolizumab in combination with chemotherapy in patients with advanced squamous cell lung cancer — clinical trials and real-world data

Magdalena Knetki-Wróblewska, Dariusz M. Kowalski

Ahead of print

Review paper

Potassium imbalances induced by systemic cancer therapy: pathophysiology and potential therapeutic strategies

Datis Kalali

Vol 20, No 1 (2024)

Review paper

Vinorelbine plus platinum compared to vinorelbine plus capecitabine in treatment of patients with metastatic triple negative breast cancer previously treated with anthracycline and taxane: a prospective randomized study

Heba Mohamed El-Zawahry, Ayman Abd Al-Samie Gaber, Amany Abd-Elhameed Abou-Bakr, Marwa Nabil Abd-Elhafez, Ahmed Mohamed El-Debawy

Vol 20, No 1 (2024)

Research paper

Low-grade serous ovarian cancer with BRAFV600E mutation treated with metronomic chemotherapy — a case report and literature review

Maria Rozpłoch-Sapa, Patrycja Mrowczyk, Łukasz Kwinta, Mateusz Łobacz, Paweł M. Potocki

Vol 20, No 1 (2024)

Case report

Do solitary pancreatic metastases of renal-cell carcinoma indicate an indolent disease with a strong indication for aggressive local treatment? A case report with literature review

Jolanta Dobrzańska, Paweł Potocki, Piotr J. Wysocki

Vol 20, No 1 (2024)

Case report

A rare case report on bilateral scrotal lipoma — the largest tumor in Vietnam

Chi Truong Nguyen, Ngoc Hieu Nguyen, Van Nguyen Huong, Ngoc Tran Pham, Thai Chan Nguyen

Vol 20, No 1 (2024)

Case report

Pulmonary tuberculosis as a differential diagnosis of a pulmonary nodule: the great masquerader

Kenneth Grenis Vargas Ponce, Claudia Meléndez Dávila, Juan Antonio Salas Lopez, Félix Llanos Tejada

Vol 20, No 1 (2024)

Case report

Clinical and economic benefits of using next-generation sequencing (NGS) in the diagnostics of patients with non-small cell lung cancer with rare mutations

Katarzyna Stencel, Bartosz Wasąg, Cezary Pruszko, Krystyna Dąbrowska, Paweł Książek, Karolina Dziadek, Maciej Bryl, Maciej Krzakowski

Ahead of print

Review paper

Predictive factors of hepatotoxicity in immunotherapy with checkpoint inhibitors in patients treated for melanoma and kidney cancer

Mateusz Malik, Zbyszko Chowaniec, Natasza Kempa-Kamińska, Jerzy Błaszczyk, Emilia Filipczyk-Cisarż

Ahead of print

Research paper

Optimizing treatment strategies for a MET exon 14 skipping mutation in non-small-cell lung cancer: a case report of sequential immunotherapy and targeted therapy and literature review

Maria Grodkiewicz, Pawel Kozieł, Izabela Chmielewska, Anna Grenda, Paweł Krawczyk, Janusz Milanowski

Vol 19, No 6 (2023)

Case report

Comprehensive geriatric assessment and clinical outcomes of frail older adults with diffuse large B-cell lymphoma: a meta-analysis

Teodoro J. Oscanoa, Xavier Vidal, Brady E. Beltran, Roman Romero-Ortuno

Vol 19, No 6 (2023)

Review paper

Metachronous breast cancer in a BRCA1 mutation carrier

Karolina Pięta, Izabela Rudy, Maksymilian Kruczała

Vol 19, No 6 (2023)

Case report

Serous cystadenocarcinoma of the pancreas with synchronous breast cancer

Martyna Ziemińska, Aldona Ząber, Andrzej Mazurek, Bartłomiej Grala, Renata Duchnowska

Vol 19, No 6 (2023)

Clinical vignette